These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19988136)

  • 21. Spinal subarachnoid haematoma after neuraxial anaesthesia in a patient with polycythaemia vera.
    Martins T; Montenegro L; Silva A; Reis H; Pereira E; Lucas P
    Anaesth Rep; 2021; 9(1):8-11. PubMed ID: 33479701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.
    Michiels JJ; Berneman ZN; Schroyens W; Van Vliet HH
    Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polycythaemia rubra vera transforming to acute lymphoblastic leukaemia with a common immunophenotype.
    Neilson JR; Patton WN; Williams MD; Mayne EE; Boughton BJ
    J Clin Pathol; 1994 May; 47(5):471-2. PubMed ID: 8027406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials.
    Mazza GL; Mead-Harvey C; Mascarenhas J; Yacoub A; Kosiorek HE; Hoffman R; Dueck AC; Mesa RA;
    Lancet Haematol; 2022 Jan; 9(1):e38-e48. PubMed ID: 34971581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of real-world data demonstrating the efficacy of current management of polycythaemia vera in attaining and maintaining therapeutic haematocrit.
    Buckley FD; Arnold C; Brass D; Catherwood M; McMullin MF
    Ir J Med Sci; 2024 Apr; 193(2):833-836. PubMed ID: 37682452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery bypass grafting in a patient with polycythaemia rubra vera - a rare indication with a spectrum of complication: a case report.
    Al-Fadhli J; Al-Shammari F; Al-Duaij A; Al-Sarraf N
    Cases J; 2009 Aug; 2():8126. PubMed ID: 19918456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary artery bypass grafting for coronary thrombosis complicating polycythaemia rubra vera. Case report.
    Gosalakkal JA; Neligan MC
    Scand J Thorac Cardiovasc Surg; 1991; 25(2):159-60. PubMed ID: 1947912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin responsiveness in polycythaemia vera.
    Golde DW; Cline MJ
    Br J Haematol; 1975 Apr; 29(4):567-73. PubMed ID: 1191565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aseptic cavernous sinus thrombosis after internal carotid arterial occlusion in polycythaemia vera.
    Melamed E; Rachmilewitz EA; Reches A; Lavy S
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):320-4. PubMed ID: 932749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary polycythaemia: diagnosis by non-conventional positive criteria.
    Westwood N; Dudley JM; Sawyer B; Messinezy M; Pearson TC
    Eur J Haematol; 1993 Oct; 51(4):228-32. PubMed ID: 8243612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycythaemia rubra vera, cerebral ischaemia and depression.
    Murray D; Hodgson R
    Br J Psychiatry; 1991 Jun; 158():842-4. PubMed ID: 1873637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polycythaemia vera--diagnosis and therapy].
    Lechner K; Geissler K; Gisslinger H
    Wien Klin Wochenschr; 1999 Aug; 111(15):582-9. PubMed ID: 10483672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased platelet thrombus formation under flow conditions in whole blood from polycythaemia vera patients.
    Vignoli A; Gamba S; van der Meijden PEJ; Marchetti M; Russo L; Tessarolo S; Giaccherini C; Swieringa F; Ten Cate H; Finazzi G; Heemskerk JWM; Falanga A
    Blood Transfus; 2022 Mar; 20(2):143-151. PubMed ID: 33819141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocyte 2,3-diphosphoglycerate and adenosine triphosphate in polycythaemia vera.
    Monti M
    Scand J Haematol; 1981 Aug; 27(2):108-10. PubMed ID: 7336161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of polycythaemia vera: an update in the JAK2 era.
    Finazzi G; Barbui T
    Intern Emerg Med; 2007 Mar; 2(1):13-8. PubMed ID: 17551678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of circulating erythroid colony-forming cells in normal and polycythaemic man.
    Mladenovic J; Adamson JW
    Br J Haematol; 1982 Jul; 51(3):377-84. PubMed ID: 7104224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the investigative approach to polycythaemia vera: a critical assessment of current evidence and vision for the future.
    Ronner L; Venugopal S; Moshier E; Mascarenhas J
    Lancet Haematol; 2021 Aug; 8(8):e605-e612. PubMed ID: 34329580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of polycythaemia vera presenting with intramuscular chest wall haematoma.
    Kheterpal S; Sayegh F; Cader A
    Postgrad Med J; 1992 May; 68(799):381-2. PubMed ID: 1630988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexistence of Polycythaemia Vera with Indolent Myeloma in the same Patient.
    Kelsey PR; Patel K
    Hematology; 1997; 2(2):139-42. PubMed ID: 27406804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycythaemia vera in a dog.
    Holden AR
    Vet Rec; 1987 May; 120(20):473-5. PubMed ID: 3603998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.